Preparing Your Poster for The Research Forum

OUCOM-TulsaDepartment of Family Medicine

Presented By:Frances Wen, Ph.D.February 23, 2010

OU-Tulsa Research Forum 2009

WHEN: Thursday, April 8, 2010

WHERE: OU Schusterman

Learning Center

The Poster Review instructions!

– 4’ x 4’– Display with velcro– Indicate all funding sources and any

conflict of interest

Poster Questions

What do I have to say? Case report or clinical investigation? Quality improvement project? Curriculum intervention or innovation? Who is your audience? Consult the “Red Book” every doc can do a

poster.http://tulsa.ou.edu/socm/documents/Every-Doc-Can-Do-Poster.doc

The Poster Write Your Text

– Expand on information provided in Abstract– Use same format as Abstract

• Introduction• Methods• Results• Conclusions/Discussion

– Implications for clinical practice– Possibilities for future studies

The Poster Consider visual presentation

– Graphs, photos, x-rays, drawings – Large font size readable from 6 feet away– Highlight important sections by size,

position or color– 50% text/pictures and 50% white space– Organize sections by how people read:

Left to Right and Top to Bottom

Common Complaints

The text is too small Too much unnecessary data or text Organization is confusing, without any

informative headings Glare from lamination or glossy paper

makes reading difficult.

Useful Design Tips Never forget the poster’s purpose,

audience and setting Use a columnar setup Use Arabic numerals or bullets to create a

visual path Experiment with alternate layouts to find

the most effective one Study other posters that you liked for

additional ideas

Type Faces and Color Justify Left margins , not Right Use upper and lower case uniformly Use muted colors for background. Avoid loud

or bright backgrounds Scale: 80 font black letters for main title 48 font for authors names and institutional

affiliations 40 font for main text headings 24-28 font for supporting text

Supporting the Poster

Presenter: This would generally be you. Dress appropriately, be professional, do not argue if you disagree with the feedback.

Handout: brief, 1 -2 page handout, synopsis of your work. Include your name and e-mail address.

Sign up List: Sign up sheet for people who are interested in more information, collaborative work, networking.

Business Card: Have your professional information ready to share.

Methods:Methods:

Double-blinded, placebo-controlled Double-blinded, placebo-controlled randomized trialrandomized trial

Intervention: Tamoxifen 20mg daily for Intervention: Tamoxifen 20mg daily for five yearsfive years

10,000 subjects enrolled10,000 subjects enrolled

Runkle GP ,Seehusen DA, Edwards JA, Junnila JL, Oh RC

Madigan Army Medical Center

Tamoxifen effective in breast cancer prevention

Family History of colon cancer increases risk

In this enterprising study, the authors demonstrated a fifty percent reduction in the ten year actuary survival rate in the incidence of breast cancer in women ages 40-59 with a first degree relative with colorectal adenocarcinoma treated with prophylactic tamoxifen at a dose of twenty milligrams daily for a total of five years of administration with minimal loss to follow-up.

Does tamoxifen reduce breast cancer risk in women with a family history of colon cancer?

Reducing the Risk of Breast Cancer: Taking 20mg of Tamoxifen daily for 5 years will reduce the 10 year risk of breast cancer in women ages 40-59 with a first degree relative of colorectal adenocarcinoma by 50 percent.

Reducing the Risk of Breast CancerSeehusen DA, Edwards JA, Junnila JL, Oh RC, Runkle GPMadigan Army Medical Center

Background:

• Tamoxifen effective in breast cancer prevention

• Family History of colon cancer increases risk

Methods:

• Double-blinded, placebo-controlled randomized trial

• Intervention: Tamoxifen 20mg daily for five years

• 10,000 subjects enrolled

Results:

50% reduction in 10 year risk of breast cancer in women ages 40-59 with a first degree relative with colorectal adenocarcinoma treated with prophylactic tamoxifen

Does tamoxifen reduce breast cancer risk in women with a family history of colon cancer?

5 year Breast Cancer Mortality

Control

Tamoxifen

(per 5,000 subjects))

Questions

References:•ACP (American College of Physicians) http://www.acponline.org/residents_fellows/competitions/abstract/prepare/index.html

“Every Doc Can Do a Poster”/”Every Doc Can Do A Case Report” http://tulsa.ou.edu/socm/documents/Every-Doc-Can-Do-Poster.dochttp://tulsa.ou.edu/socm/documents/Every-Doc-Can-Do-CaseReport.doc

Thank You